Literatur
- 1
Burris HA, Moore MJ, Andersen J. et al .
Improvements in survival and clinical benefit with gemcitabine as first-line therapy
for patients with advanced pancreas cancer: A randomized trial. .
J Clin Oncol .
1997; ;
15
2403-2413
- 2
Eberl T, Graeven U, Heike M. et al .
ASCO Update 2003 - Highlights of the 39th Meeting of the American Society of Clinical
Oncology/ASCO 2003.
Z Gastroenterol.
2003;
41
1039-1045
- 3
Macdonald J S, Smalley S R, Benedetti J. et al .
Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of
the stomach or gastroesophageal junction.
N Engl J Med.
2001;
345
725-730
- 4
Ott K, Fink U, Becker K. et al .
Prediction of response to preoperative chemotherapy in gastric carcinoma by metabolic
imaging: results of a prospective trial.
J Clin Oncol.
2003;
21
4604-4610
PD Dr. med. Thomas Seufferlein
Abt. Innere Medizin I, Medizinische Klinik, Universität Ulm
Robert-Koch-Straße 8
89081 Ulm
